Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases

This publication has 113 references indexed in Scilit:

• REGULATION OF B CELL FUNCTION BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1
  Transplantation, 1996
• The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited
  Trends in Biochemical Sciences, 1995
• Blood Distribution and Single-Dose Pharmacokinetics of Leflunomide
  Therapeutic Drug Monitoring, 1995
• Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound
  Journal of Biological Chemistry, 1995
• Leflunomide: Inhibition of S-antigen induced autoimmune uveitis in Lewis rats
  Inflammation Research, 1994
• The influence of leflunomide on cell cycle, IL-2-receptor (IL-2-R) and its gene expression
  Inflammation Research, 1994
• De novo synthesis of pyrimidine nucleotides by Helicobacter pylori
  Journal of Applied Bacteriology, 1994
• LEFLUNOMIDE IN EXPERIMENTAL TRANSPLANTATION
  Transplantation, 1994
• Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assembly
  Biochemistry and Cell Biology, 1990
• The use of the murine chronic graft Vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery
  Inflammation Research, 1987